000 01253 a2200337 4500
005 20250514221825.0
264 0 _c20050331
008 200503s 0 0 eng d
022 _a1473-3099
024 7 _a10.1016/S1473-3099(05)01307-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGroneberg, David A
245 0 0 _aTreatment and vaccines for severe acute respiratory syndrome.
_h[electronic resource]
260 _bThe Lancet. Infectious diseases
_cMar 2005
300 _a147-55 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aAntiviral Agents
_xtherapeutic use
650 0 4 _aDisease Outbreaks
_xprevention & control
650 0 4 _aHumans
650 0 4 _aSevere acute respiratory syndrome-related coronavirus
_xdrug effects
650 0 4 _aSevere Acute Respiratory Syndrome
_xdrug therapy
650 0 4 _aViral Vaccines
700 1 _aPoutanen, Susan M
700 1 _aLow, Donald E
700 1 _aLode, Hartmut
700 1 _aWelte, Tobias
700 1 _aZabel, Peter
773 0 _tThe Lancet. Infectious diseases
_gvol. 5
_gno. 3
_gp. 147-55
856 4 0 _uhttps://doi.org/10.1016/S1473-3099(05)01307-1
_zAvailable from publisher's website
999 _c15439407
_d15439407